Publication | Closed Access
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors
103
Citations
61
References
2023
Year
Hematological MalignancyCancer ImmunosurveillanceCytotoxic T CellsMedicineMalignant Blood DisorderImmunologyHematologyPathologyBlood-borne MyeloidsBrain TumorsAutoimmunityAntigen ProcessingImmunotherapyNeuroimmunology
| Year | Citations | |
|---|---|---|
Page 1
Page 1